4,4,5,5-Tetramethyl-2-(spiro[fluorene-9,9'-xanthen]-4-yl)-1,3,2-dioxaborolane, 98%, 5g

TERT-BUTYL 4-(1,1-DIFLUORO-2-HYDROXYETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 500mg

Olopatadine Hydrochloride, >98.0%(HPLC)(T), 5g

(R)-2,3-Bis((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid, 95%, 1g

Entonnoir à séparation selon. à Gilson, 50 ml, 2 pièce(s)

5-Chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 5g

1,6-Dibromopyrene>98.0%(GC)5g

(2s,4s)-1-(((9h-Fluoren-9-yl)methoxy)carbonyl)-4-(trifluoromethyl)pyrrolidine-2-carboxylic acid, 98%, 100mg

2-(Cyclopropylmethoxy)nicotinaldehyde, 95.0%, 1g

4-(hydroxymethyl)-2,6-dimethylphenol, 95%, 250mg

3,4-Dihydroxybenzonitrile, 95.0%, 25g

Benzeneethanol, 2,4-difluoro-, 95.0%, 1g

Thieno[2,3-c]pyridine-2-carboxamide, 4-[(4-methylphenyl)thio]-, 98%, 100mg